Description
Motesanib (AMG 706) is a multi-targeted anticancer agent with an inhibitory action on human vascular endothelial growth factor receptors 1, 2 and 3 (VEGFR1-3), platelet-derived growth factor receptor (PDGFR) and cellular stem-cell factor receptor (c-KIT)